secwatch.observer — SEC 8-K summary
======================================

Issuer:     SCYNEXIS INC (SCYX)
CIK:        0001178253
Form:       8-K
Filed at:   2022-10-20T23:59:59+00:00
Accession:  0001564590-22-034777
Event type: leadership
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.02, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

SCYNEXIS CEO to retire Dec 31; appoints new CEO David Angulo and CFO Ivor Macleod
--------------------------------------------------------------------------------

- CEO Marco Taglietti to retire Dec 31, 2022; separation extends stock option exercise period to 4 years.
- David Angulo (CMO) becomes President & CEO Jan 1, 2023; salary $565K, bonus 55%, option 165K shares, RSU 110K shares.
- Ivor Macleod joins as CFO Oct 24, 2022; salary $435K, bonus 40%, option 170K shares, RSU 15K shares.
- Interim CFO Larry Hoffman to step down; Chief Commercial Officer Christine Coyne to depart Nov 30, 2022.
- Company to out-license BREXAFEMME, wind down promotion, focus ibrexafungerp on hospital indications.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178253/000156459022034777/0001564590-22-034777-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178253/000156459022034777/scyx-8k_20221014.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-034777

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer